ALG VERSUS OKT3 PROPHYLAXIS IN RENAL-TRANSPLANT PATIENTS WITH HIGH IMMUNOLOGICAL RISK

被引：0
|
作者：
OSORIO, JM [1 ]
BIECHY, M [1 ]
OSUNA, A [1 ]
MARTINEZ, E [1 ]
SORIANO, C [1 ]
ASENSIO, C [1 ]
机构：
[1] HOSP VIRGEN NIEVES,SERV NEFROL,GRANADA,SPAIN
来源：
KIDNEY INTERNATIONAL | 1994年 / 46卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：584 / 584
页数：1
相关论文
共 50 条
  • [21] OKT3 IN SEVERE EARLY REJECTION - PREDICTORS FOR REVERSAL IN RENAL-TRANSPLANT RECIPIENTS
    SUMRANI, N
    DELANEY, V
    RAJPOOT, D
    TEJANI, A
    BUTT, K
    HONG, J
    TRANSPLANTATION PROCEEDINGS, 1990, 22 (04) : 1750 - 1752
  • [22] EFFECT OF OKT3 ANTIBODY THERAPY ON CYTOMEGALOVIRUS REACTIVATION IN RENAL-TRANSPLANT RECIPIENTS
    CHOU, S
    NORMAN, DJ
    TRANSPLANTATION PROCEEDINGS, 1985, 17 (06) : 2755 - 2756
  • [23] MORBIDITY OF INTRAOPERATIVE OKT3 ADMINISTRATION IN PRIMARY CADAVERIC RENAL-TRANSPLANT RECIPIENTS
    KUPIN, W
    VENKAT, KK
    IKEMIYASHIRO, D
    OCDOL, H
    MOZES, M
    ANAISE, D
    JOHNSON, C
    TRANSPLANTATION PROCEEDINGS, 1993, 25 (01) : 572 - 574
  • [24] INTERVAL ALG THERAPY IN HIGH-RISK CADAVERIC RENAL-TRANSPLANT PATIENTS
    JARRELL, B
    BURKE, J
    YANG, S
    KARSCH, R
    BESARAB, A
    KIDNEY INTERNATIONAL, 1983, 23 (01) : 291 - 291
  • [25] CYCLOSPORINE MONOTHERAPY VERSUS OKT3 AND CYCLOSPORINE VERSUS PREDNISONE AND CYCLOSPORINE AS INDUCTION THERAPY IN OLDER RENAL-TRANSPLANT PATIENTS - A MULTICENTER RANDOMIZED STUDY
    FRANCO, A
    OLIVARES, J
    GRINO, JM
    MORENO, F
    OPPENHEIMER, J
    VILARDELL, J
    CAPDEVILA, L
    PIERA, L
    ALONSO, A
    VALDES, F
    RENGEL, M
    VALDERRABANO, F
    MARCEN, R
    RIVERA, MT
    ANDRES, A
    MORALES, JM
    CABELLO, M
    MOLINA, MG
    ARIAS, M
    ESCALLADA, R
    POSADAS, JMG
    MACEIRA, B
    PALLARDO, LM
    PLUMED, JS
    AMENABAR, JJ
    LAMPREAVE, I
    COLON, JAG
    RAMOS, JP
    TRANSPLANTATION PROCEEDINGS, 1994, 26 (05) : 2522 - 2524
  • [26] HEMOLYTIC-UREMIC SYNDROME IN A RENAL-TRANSPLANT RECIPIENT DURING OKT3 THERAPY
    DUSSOL, B
    BRUNET, P
    VACHERCOPONAT, H
    SAINGRA, Y
    CASANOVA, P
    BERLAND, Y
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1994, 9 (08) : 1191 - 1193
  • [27] CONCOMITANT LOW-DOSE CYCLOSPORINE AND OKT3 THERAPY FOR RENAL-TRANSPLANT REJECTION
    HRICIK, DE
    ZARCONI, J
    SCHULAK, JA
    TRANSPLANTATION PROCEEDINGS, 1989, 21 (01) : 1755 - 1757
  • [28] IMPROVING RENAL-TRANSPLANT OUTCOMES IN AFRICAN-AMERICANS WITH OKT3 INDUCTION THERAPY
    LIGHT, JA
    KELLY, JL
    AQUINO, A
    NEU, L
    DENAVAS, L
    WILLIAMS, K
    TRANSPLANTATION PROCEEDINGS, 1993, 25 (04) : 2436 - 2438
  • [29] PROLONGED NEUROLOGICAL DISABILITY FOLLOWING OKT3 THERAPY FOR ACUTE RENAL-TRANSPLANT REJECTION
    JEFFREY, RF
    JOHNSON, MH
    BAMFORD, JM
    GILES, GR
    BROWNJOHN, AM
    WILL, EJ
    TRANSPLANTATION, 1993, 55 (03) : 677 - 679
  • [30] TOXICITY OF OKT3 INCREASES WITH DOSAGE - A CONTROLLED-STUDY IN RENAL-TRANSPLANT RECIPIENTS
    PARLEVLIET, KJ
    BEMELMAN, FJ
    YONG, SL
    HACK, CE
    SURACHNO, J
    WILMINK, JM
    TENBERGE, IJM
    SCHELLEKENS, PTA
    TRANSPLANT INTERNATIONAL, 1995, 8 (02) : 141 - 146
12345